Commence Bio to Present at 2015 Stem Cell Meeting on the Mesa

SPARKS, MD, Oct 01, 2015 (Marketwired via COMTEX) — Commence Bio, Inc., a biotechnology company focused on the development of MSC1 and MSC2 cellular immunotherapy platforms for cancer and inflammatory diseases, announced today that Thomas Isett, Chief …

[Read the full article here]

Comments are closed.